William A. Haseltine, Contributor

As one of the most primitive parts of our nervous system, the vagus nerve controls many aspects of the body that are outside our conscious control.

Viroids and virusoids are the smallest known pathogens. They have traditionally been considered fairly uncommon; new research challenges this assumption.

Advances in wearable sensor technology may improve health outcomes for those at risk of mobility limitation later in life.

The future of cancer treatment may involve two modern technologies: mRNA and CAR T Therapy. Here, we describe an example using multiple myeloma.

This article will discuss some of the most promising gene therapies for age-related macular degeneration, including ADVM-022, RGX-314, GT-005, and HMR59.

Advances in MRI microstructure biomarker identification may help stop long-term brain injury in athletes before it’s too late.

Contrary to previous assumptions, hepatitis D virus-like agents seem to be active in a range of different animal species, from fish all the way to termites.

The application of gene therapy to restoring vision has been especially fruitful. Here we discuss the potential of gene therapy to address macular degeneration.

Enhanced microrobots in our bloodstream may be the next step forward for therapeutic delivery technology.

Newly released study results demonstrate that Yescarta, a CAR T therapy, prolongs survival longer than standard care for patients with early relapsed or refractory DLBCL